RecruitingNot ApplicableNCT04766190

DISCO: A Patient Intervention to Reduce the Financial Burden of Cancer


Sponsor

Lauren Hamel

Enrollment

260 participants

Start Date

Feb 10, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The DISCO App is designed to improve, during the interaction, patient active participation and patient-initiated oncologist treatment cost discussions, and, in the short term, patient's treatment cost knowledge, self-efficacy for managing both cost and physician interactions, referrals, perceived financial toxicity (i.e., distress and material hardship); in turn, these will affect longer-term outcomes of financial toxicity and adherence.


Eligibility

Min Age: 18 Years

Inclusion Criteria2

  • Oncologists are eligible if they treat patients with breast, prostate, lung, or colorectal cancers at Karmanos Cancer Institute. Data from oncologists will include their self-report data and video-recorded treatment discussions with participating patients.
  • Patients: Must be able to read and write in English; have an email account; and are newly diagnosed with breast, prostate, lung or colorectal cancer (stage I-IV) for which systemic therapy is a likely recommended treatment. Data from patients will include their self-report data, video-recorded treatment discussions with participating oncologists, and medical record data

Exclusion Criteria1

  • \-

Interventions

BEHAVIORALGroup 2: The DISCO App

Patients will receive an individually-tailorable cancer treatment cost education and communication intervention delivered on an iPad just prior to meeting with their oncologist.

BEHAVIORALGroup 1: Usual Care

Patients randomized to this arm will receive usual care.

BEHAVIORALGroup 3: The DISCO App + Booster

Patients will receive an individually-tailorable cancer treatment cost education and communication intervention delivered on an iPad just prior to meeting with their oncologist. Then, 2 months later they will receive an intervention booster in the form of an individually-tailored email to remind patients of the contents of the intervention.


Locations(1)

Barbara Ann Karmanos Cancer Institute

Detroit, Michigan, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04766190


Related Trials